History Says This Low-Cost Investment Could Outperform Anthropic -- and You Might Already Own It

Anthropic is reportedly targeting a $100 billion IPO raise, potentially in November, following SpaceX's record $86.7 billion IPO in June. The article cautions that large IPOs often underperform, citing Lineage's 53% decline since its 2024 listing and SpaceX currently lagging the S&P 500. It argues that Vanguard's S&P 500 ETF, with $1.8 trillion in assets and a 0.03% expense ratio, offers lower-risk exposure to major AI and growth companies; the index has returned an average 11.3% annually over the past 20 years.

Analysis

The investable implication is not a broad S&P 500 allocation call; it is a prospective valuation-discovery event for AI application economics. A successful Anthropic listing at an aggressive revenue multiple would support private-market marks for OpenAI-adjacent infrastructure and enterprise-AI vendors, but could also expose how much current public AI multiples rely on assumed downstream software monetization. AMZN is the most direct listed read-through through cloud demand and strategic exposure, while NVDA benefits only if disclosed model-training and inference spending confirms sustained compute intensity rather than a shift toward efficiency.

Near term, IPO marketing can create a sentiment bid in AI beneficiaries, particularly NVDA, AMZN, and META, but the more important 1-3 month catalyst is the registration statement: revenue concentration, gross-margin trajectory, committed cloud spend, stock-based compensation, and customer-retention disclosures will matter far more than the headline valuation. A large float could also divert incremental growth-fund liquidity from incumbent AI leaders, creating temporary multiple pressure even if fundamentals remain intact. This is a limited risk for VOO/SPY given index depth, but more material for concentrated AI momentum baskets.

The contrarian view is that a well-received deal may be bearish for parts of public AI software rather than universally bullish: transparent evidence that frontier models are becoming commoditized or that inference costs remain structurally high would compress premium application-layer multiples. Conversely, weak aftermarket performance would not by itself invalidate AI capex; it could simply reset private-company valuation expectations and improve the strategic position of cash-rich incumbents AMZN, META, and MSFT. There is no standalone trade from the article today; the actionable signal requires prospectus-level operating data and deal terms.

Key Decisions for Investors

• Maintain core AI exposure through AMZN over higher-beta single-product AI names into the expected filing window; AMZN has both cloud-demand upside and balance-sheet capacity to absorb AI investment. Reassess if AWS growth fails to reaccelerate or AI-related capex rises without corresponding cloud margin support over the next two earnings reports.
• Set an event-driven alert for Anthropic filing disclosures: if annualized revenue growth is above 75%, net retention exceeds 120%, and committed compute obligations are manageable relative to gross profit, add a tactical long NVDA/short IGV pair for 1-3 months. The pair expresses infrastructure demand while hedging application-software multiple compression; exit on evidence of falling training/inference intensity.
• Avoid chasing SPCX or broad IPO-beta proxies solely on IPO enthusiasm. Use a weak aftermarket or a deal priced below its indicated range as a signal to reduce crowded AI-momentum exposure, not as evidence of deteriorating semiconductor demand.
• For diversified mandates, prefer SPY or VOO to a pre-IPO allocation strategy; treat any post-listing index-inclusion flows as a multi-year, not launch-date, catalyst. The thesis is falsified if the new issuer achieves durable scale but remains excluded from major benchmarks because of governance, float, or profitability constraints.